Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAMP-BG vs Biodentine in Pulpotomized Primary Teeth
NCT03786302Phase 2Terminated
- Start
- Dec 2016
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 2, randomised trial (2 arms). Primary endpoints: Absence of clinical signs of pulp degeneration at 12 months and Absence of radiographic signs of pulp degeneration at 12 months. Started Dec 2016; status: terminated.
Beyond the preview
Go deeper on NCT03786302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03786302.